Precision BioSciences, Inc.
DTIL
$6.30
$0.6311.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 263,007.69% | -27.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 263,007.69% | -27.78% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 263,007.69% | -27.78% | |||
| SG&A Expenses | -9.74% | -19.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.91% | -5.55% | |||
| Operating Income | 160.52% | 5.53% | |||
| Income Before Tax | 188.41% | 7.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 188.41% | 7.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 192.47% | 7.43% | |||
| EBIT | 160.52% | 5.53% | |||
| EBITDA | 163.26% | 5.50% | |||
| EPS Basic | 157.36% | 13.47% | |||
| Normalized Basic EPS | 156.05% | 13.38% | |||
| EPS Diluted | 156.99% | 13.51% | |||
| Normalized Diluted EPS | 155.71% | 13.38% | |||
| Average Basic Shares Outstanding | 61.20% | 6.99% | |||
| Average Diluted Shares Outstanding | 62.22% | 6.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||